Gil D. Rabinovici

Neurology
400 Parnassus Ave
Mcb300
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 414 publications

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

Journal: Neurology
Published: August 26, 2026

Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21.

Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21.

Journal: BMJ (Clinical research ed.)
Published: August 25, 2026

In-clinic validation of a smartphone-based finger tapping test for use in neurodegenerative and neurological populations.

In-clinic validation of a smartphone-based finger tapping test for use in neurodegenerative and neurological populations.

Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026

The Dynamic Affect Recognition Test: Construction and Validation in Neurodegenerative Syndromes.

The Dynamic Affect Recognition Test: Construction and Validation in Neurodegenerative Syndromes.

Journal: Assessment
Published: July 16, 2026

Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.

Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Traumatic Encephalopathy.

Journal: JAMA network open
Published: July 13, 2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA
Published: July 13, 2026

Ceperognastat in Alzheimer Disease: Lessons From a Negative Clinical Trial.

Ceperognastat in Alzheimer Disease: Lessons From a Negative Clinical Trial.

Journal: JAMA
Published: July 13, 2026

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

Characterisation of Posterior Predominant Amyloid PET Binding Across Multiple Cohorts.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers.

Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers.

Journal: JAMA neurology
Published: June 29, 2026

Beyond Binary-The Case for Amyloid Centiloid Quantification.

Beyond Binary-The Case for Amyloid Centiloid Quantification.

Journal: JAMA
Published: June 17, 2026

The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral Complaints.

The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral Complaints.

Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026

The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral Complaints.

The BEYONDD Pilot Study: A Decentralized Community-Engaged Research Framework for Multimodal Characterization of Neurodegenerative Risk in a Multi-Ethnic, Midlife Cohort with Subjective Cognitive or Behavioral Complaints.

Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026
Showing 1-12 of 414

Last Updated: 09/26/2026